City of Hope Intensive Course in Genomic Cancer Risk Assessment
Accepting applications until August 1
City of Hope Intensive Course in Genomic Cancer Risk Assessment
Accepting applications until August 1
Accepting applications until August 1
Accepting applications until August 1
We invite you to join the ISOPT community to receive free updates, newsletters, and information on upcoming events.
September 24-26, 2026
Hong Kong, China
World Cancer Congress 2026 will be organized in collaboration with the Hong Kong Anti-Cancer Society, a long-standing UICC member organization.
Learn More
Mission Statement: ISOPT unites the world in cancer prevention and early detection. Through free multilingual virtual education, we help equip physicians, nurses, genetic counselors, patient advocates, policymakers, and at-risk individuals with the knowledge to assess risk, implement prevention strategies, detect cancer early, and provide multidisciplinary care. Reaching globally across all six continents—we transform education into lives saved.
Charitable Contributions and Other Payments. The International Society of Prevention and Treatment USA Inc. (“ISOPT USA”) is a qualified public charity under Section 501(c)(3) of the US Internal Revenue Code. Your contributions and support of our events are considered a charitable donation to the extent permitted by law. Tax ID Number 39-5091295.
Contact us: info@isopt.health
European Cancer Organisation, shared a post on LinkedIn: “At our next Community 365 Roundtable on 13 July, Lis Puga, research manager of the EuroACT project, will present the project’s dashboard, …
Jason R. Williams, Founder and Director of Interventional Oncology and Immunotherapy at Williams Cancer Institute, shared a post on X: “In the clinic I have seen a damaged liver heal on …
David Wazer, Professor and Chairman of Radiation Oncology at Brown University Health, shared a post on LinkedIn: “A Looming Collapse: Radiation Oncology’s Access Crisis Is No Longer Theoretical For years, warnings about …
Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical Schoolpost, shared a post on X: “Neoadjuvant THP x12 will likely soon become a SoC for many patients with stage II …
Emad Shash, General Manager at National Cancer Institute, Cairo University, shared a post on LinkedIn: “Allhamdoullah. I am proud to share that our team at the Breast Cancer Comprehensive Center, National …
Rupam Manna, Medical Oncologist, Entrepreneur, interested in Metabolism education and brain science, shared a post on LinkedIn: “MMR or MSI? One of the most common areas of confusion in oncology …